Company Filing History:
Years Active: 2011-2023
Title: Vladimir Ladziata: Innovator in Pharmaceutical Chemistry
Introduction
Vladimir Ladziata is a prominent inventor based in Ewing, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective ROCK inhibitors. With a total of 10 patents to his name, Ladziata's work has the potential to impact various medical conditions.
Latest Patents
Ladziata's latest patents focus on 5-membered and bicyclic heterocyclic amides as inhibitors of ROCK. The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
Career Highlights
Ladziata is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of various diseases.
Collaborations
Some of his notable coworkers include Peter W. Glunz and Xiaojun Zhang, who have collaborated with him on various projects within the pharmaceutical domain.
Conclusion
Vladimir Ladziata's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.